IXICO reduces FY loss
Shares in IXICO were up more than 3% as the company reported a first-half pre-tax loss of £793,000, an improvement from a loss of £1.1m a year previous.
FTSE AIM All-Share
728.67
15:45 15/11/24
n/a
n/a
Ixico
8.73p
09:45 15/11/24
-0.26%
-0.02p
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
-2.70%
-535.19
The company had lifted its revenue to £2.0m, from £1.5m.
Chiev executive Giulio Cerroni said IXICO's operational performance in the first half of this financial year had delivered a strong increase in revenue, improved gross profit margin performance and reduced losses.
"As we proceed into the second half I am excited to be executing plans that focus on accelerating our growth through optimising operational delivery and our integrated digital technologies to drive scale and commercial success."
At 12:20 BST, shares in AIM-traded IXICO were up 3.28% to 31.5p each.